108 related articles for article (PubMed ID: 33031375)
1. Multidisciplinary team discussion results in survival benefit for patients with stage III non-small-cell lung cancer.
Hung HY; Tseng YH; Chao HS; Chiu CH; Hsu WH; Hsu HS; Wu YC; Chou TY; Chen CK; Lan KL; Chen YW; Wu YH; Chen YM
PLoS One; 2020; 15(10):e0236503. PubMed ID: 33031375
[TBL] [Abstract][Full Text] [Related]
2. The utilization of multidisciplinary tumor boards (MDT) in clinical routine: results of a health care research study focusing on patients with metastasized colorectal cancer.
Lowes M; Kleiss M; Lueck R; Detken S; Koenig A; Nietert M; Beissbarth T; Stanek K; Langer C; Ghadimi M; Conradi LC; Homayounfar K
Int J Colorectal Dis; 2017 Oct; 32(10):1463-1469. PubMed ID: 28779354
[TBL] [Abstract][Full Text] [Related]
3. Improved overall survival for Stage III NSCLC patients treated with curative-intended therapy from 2010 to 2018-a cohort study in Denmark.
Meldgaard P; Kristensen M; Conte S; Kaae Andersen K; Jovanovic A; Meldgaard E
Acta Oncol; 2023 Dec; 62(12):1672-1679. PubMed ID: 37699061
[TBL] [Abstract][Full Text] [Related]
4. Tumor board participation among physicians caring for patients with lung or colorectal cancer.
Kehl KL; Landrum MB; Kahn KL; Gray SW; Chen AB; Keating NL
J Oncol Pract; 2015 May; 11(3):e267-78. PubMed ID: 25922221
[TBL] [Abstract][Full Text] [Related]
5. Impact of multidisciplinary team management in head and neck cancer patients.
Friedland PL; Bozic B; Dewar J; Kuan R; Meyer C; Phillips M
Br J Cancer; 2011 Apr; 104(8):1246-8. PubMed ID: 21448166
[TBL] [Abstract][Full Text] [Related]
6. Effect of multidisciplinary team care on the risk of recurrence in breast cancer patients: A national matched cohort study.
Tsai CH; Hsieh HF; Lai TW; Kung PT; Kuo WY; Tsai WC
Breast; 2020 Oct; 53():68-76. PubMed ID: 32652461
[TBL] [Abstract][Full Text] [Related]
7. Multidisciplinary meeting review in nonsmall cell lung cancer: a systematic review and meta-analysis.
Stirling RG; Harrison A; Huang J; Lee V; Taverner J; Barnes H
Eur Respir Rev; 2024 Apr; 33(172):. PubMed ID: 38719736
[TBL] [Abstract][Full Text] [Related]
8. Multidisciplinary team consultation for resectable Gastric Cancer: A propensity score matching analysis.
Chen Y; Xiang J; Liu D; Xiao J; Xiong F; Wei K; Liu A; Chen S; Zhu Y; Meng X; Peng J
J Cancer; 2021; 12(7):1907-1914. PubMed ID: 33753988
[No Abstract] [Full Text] [Related]
9. ReCAP: Impact of Multidisciplinary Care on Processes of Cancer Care: A Multi-Institutional Study.
Onukwugha E; Petrelli NJ; Castro KM; Gardner JF; Jayasekera J; Goloubeva O; Tan MT; McNamara EJ; Zaren HA; Asfeldt T; Bearden JD; Salner AL; Krasna MJ; Das IP; Clauser SB; Onukwugha E; Petrelli NJ; Castro KM; Gardner JF; Jayasekera J; Goloubeva O; Tan MT; McNamara EJ; Zaren HA; Asfeldt T; Bearden JD; Salner AL; Krasna MJ; Prabhu Das I; Clauser SB
J Oncol Pract; 2016 Feb; 12(2):155-6; e157-68. PubMed ID: 26464497
[TBL] [Abstract][Full Text] [Related]
10. Offering a prognosis in lung cancer: when is a team of experts an expert team?
Kee F; Owen T; Leathem R
J Epidemiol Community Health; 2007 Apr; 61(4):308-13. PubMed ID: 17372290
[TBL] [Abstract][Full Text] [Related]
11. Optimizing Outcomes through a Multidisciplinary Team Approach in Endometrial Cancer.
Mangone L; Marinelli F; Bisceglia I; Braghiroli MB; Mastrofilippo V; Pezzarossi A; Morabito F; Aguzzoli L; Mandato VD
Healthcare (Basel); 2023 Dec; 12(1):. PubMed ID: 38200970
[TBL] [Abstract][Full Text] [Related]
12. Clinicians' knowledge and understanding regarding multidisciplinary treatment implementation: a study in municipal public class III grade A hospitals in Southwest China.
Zhong X; Zeng X; Zhao L; TaoChen ; Min X; He R
BMC Med Educ; 2023 Dec; 23(1):916. PubMed ID: 38049733
[TBL] [Abstract][Full Text] [Related]
13. Application of Minimally Invasive Surgery-Multidisciplinary Team in Advanced and Recurrent Gynecological Cancers: 10-Year Exploration and Practice.
Li C; Wang Z; Yang W; Ai G; Cheng Z
Gynecol Minim Invasive Ther; 2023; 12(3):141-147. PubMed ID: 37807982
[TBL] [Abstract][Full Text] [Related]
14. Sufficient Multidisciplinary Discussion Can Make Patients' Outcomes Better in the Treatment for Stage III Non-Small-Cell Lung Carcinoma - Reply to Ohri et al.
Adachi H; Ito H; Isaka T; Saito H; Yoshida D; Yokose T; Saito A
Clin Lung Cancer; 2024 Mar; 25(2):e73-e74. PubMed ID: 38000972
[No Abstract] [Full Text] [Related]
15. A multidisciplinary discussion of BladderPath.
St-Laurent MP; Sfakianos JP; Rose TL; Chung P; Kassouf W; Zlotta AR; Inman B; Black PC
Can Urol Assoc J; 2024 Mar; 18(3):E91-E92. PubMed ID: 38010224
[No Abstract] [Full Text] [Related]
16. Comparison of First-Line Treatments for Patients With Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-analysis.
Zhou T; Zhang Z; Luo F; Zhao Y; Hou X; Liu T; Wang K; Zhao H; Huang Y; Zhang L
JAMA Netw Open; 2020 Oct; 3(10):e2015748. PubMed ID: 33074323
[TBL] [Abstract][Full Text] [Related]
17. Preoperative lymphocyte-to-monocyte ratio versus platelet-to-lymphocyte ratio as a prognostic predictor for non-small cell lung cancer patients.
Yan H; Cai L; Chen S; Li J
J Med Biochem; 2020 Jan; 39(2):160-164. PubMed ID: 33033447
[TBL] [Abstract][Full Text] [Related]
18. Continued gefitinib retreatment beyond progression in patients with advanced non-small cell lung cancer harboring sensitive
Jiang X; Li X; Tu L; Cai J; Wei M; Wu Z; Sun L
J Int Med Res; 2020 Oct; 48(10):300060520955030. PubMed ID: 33032475
[TBL] [Abstract][Full Text] [Related]
19. The clinical manifestations and interval changes of reverse-transcriptase quantitative polymerase chain reactions among different specimens of coronavirus disease 2019 patients.
Chen PL; Hsiao YH; Chuang C; Feng JY; Ho HL; Lin YT; Chen SJ; Huang SF; Chen HP; Chou TY; Chen YM; Wang FD
J Chin Med Assoc; 2021 Feb; 84(2):151-157. PubMed ID: 33177406
[TBL] [Abstract][Full Text] [Related]
20. Factors influencing multi-disciplinary tumor board recommendations in stage III non-small cell lung cancer.
Ronden MI; Bahce I; Hashemi SMS; Dickhoff C; de Haan PF; Becker A; Spoelstra FOB; Dahele MR; Ali R; Tiemessen MA; Tarasevych S; Maassen van den Brink K; Haasbeek CJA; Daniels JMA; van Laren M; Verbakel WFAR; Senan S
Lung Cancer; 2021 Feb; 152():149-156. PubMed ID: 33418430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
